View Older Stories View More Recent Stories
-
JinkoSolar (JKS) Falls as Analyst Doesn't See 'Take Private' Move
-
DSMB Decision on Celldex's (CLDX) RINTEGA was No Surprise; 'Focus Pick' Rating Reaffirmed
-
Sarepta Therapeutic (SRPT) NDA Submission Marks 'Significant De-risking Event', Roth Capital Says
-
Roth Capital Cuts Price Target on Micron Technology (MU) Following 3Q15 Results
-
Sapiens International (SPNS) PT to $12 at Roth Capital
-
Roth Capital Downgrades China Cord Blood (CO) to Neutral
-
Celator's (CPXX) CPX-351 Has Room to Grow in AML Space; Roth Capital Affirms at 'Buy'
-
Roth Positive on Keryx (KERX) Following Addition of Auryxia to Two Medicare Part D Formularies
-
Inphi Corp. (IPHI) PT Lifted to $30 at Roth Capital
-
Aethlon Medical Announces $6 Million Equity Investment
-
bluebird bio (BLUE) Prices 2.9M Common Share Offering at $170/Share
-
Roth Capital Starts Interactive Intelligence (ININ) at Buy
-
Roth Capital Starts Sphere 3D Corporation (ANY) at Buy
-
bluebird bio Announces Pricing of Public Offering of Common Stock
-
Ring Energy, Inc. Announces Completion of Public Common Stock Offering of 4,500,000 Shares
-
bluebird bio (BLUE) Announces $400M Common Stock Offering
-
bluebird bio Announces Proposed Public Offering of Common Stock
-
INVESTOR ALERT: Class Action Lawsuit Against Iconix Brand Group, Inc. Filed by Glancy Prongay & Murray LLP
-
Streetinsider.com's Hot Lunchtime Reads 6/23: (GOOG) (WMT) (UAL) (DMRC)
-
Roth Capital Downgrades Vical (VICL) to Neutral
-
Roth Capital Raised Price Target on Escalade (ESCA) Following Investor Meetings
-
Sequential Brands (SQBG) Announces Acquisition of Martha Stewart Living Omnimedia (MSO); Roth Capital Raises Price Target to $20
-
Magellan Petroleum (MPET) Flagship Results Better Than Expected; Roth Capital Raises Price Target to $2
-
Quest Resource Holding Corporation to Participate in ROTH Cleantech Investor Day in London on June 25, 2015
-
Roth Capital Previews Preclinical PRESERVATION-1 Data; Affirms BioLineRx (BLRX) at 'Buy'
-
Orbite to Participate in a Cleantech Investor Event in London, U.K.
-
Roth Capital Starts NTN Buzztime (NTN) at Neutral
-
Ameresco to Present at ROTH London Cleantech Day
-
Roth Capital Sees SodaStream (SODA) Results Lackluster Short Term But Rebounding in Q4; PT to $29
-
TG Therapeutics (TGTX) Data Acts as Strong GENUINE Proxy, Roth Capital Says
-
Ring Energy (REI) Prices 4.5M Common Stock Offering at $11.50/Share
-
Ring Energy, Inc. Announces Pricing of Public Offering of Common Stock
-
Competitor IPO Filing Shows Callidus Software's (CALD) Srength; Roth Capital reiterates Buy
-
Roth Capital Remains Bullish on Align Technology (ALGN) After ClearCorrect's Patent Reexamination Request was Granted
-
Roth Capital Cuts PT on Capstone Turbine (CPST) to 50c; Challenging End Markets Hamper Q4 Results
-
Eco-stim Energy Solutions (ESES) Announces $30M Common Offering
-
Eco-Stim Energy Solutions Announces Public Offering of Shares of Common Stock
-
Eco-Stim Energy Solutions Announces Public Offering of Shares of Common Stock
-
ROTH Capital Partners to Host Cleantech Day in London on June 25, 2015
-
Roth Capital Downgrades Insite Vision (INSV) to Neutral
-
BioCardia (BCDA) Files $57.5M Common Stock IPO
-
Spark Therapeutics to Participate in Two International Conferences in London in June
-
Spark Therapeutics to Participate in Two International Conferences in London in June
-
Roth Capital Starts Quest Resource (QRHC) at Buy
-
BioCardia, Inc. Files Registration Statement for Proposed Initial Public Offering
-
ROTH Capital Partners to Host Healthcare Day In London on June 24, 2015
-
Roth Capital Remains Bullish Following Motorcar Parts of America (MPAA) FQ4 Beat
-
Roth Capital Starts Trevena (TRVN) at Buy, $14.50 PT
-
Roth Capital Raises Price Target on Iradimed Corp. (IRMD) After traveling with Management
-
Pace of ECCO-50 Development in OA Patients Remains Robust; Roth Affirms Cytori Therapeutics (CYTX) at 'Buy'

